FY26 results: revenue up 51%, PAT rises 73% to Rs 5.35 cr
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Astonea Labs (BSE SME) reported FY26 consolidated revenue of Rs 147.58 crores, up 51% from Rs 97.52 crores. PAT rose 73% to Rs 5.35 crores from Rs 3.10 crores. EPS at Rs 4.49 vs Rs 6.94 (share dilution post IPO). Auditor gave unmodified opinion. Emphasis of matter: factory fire causing Rs 9.39 cr loss (insurance claim pending). Operating cashflow was negative at Rs 13.65 crores.
Strong post-IPO growth in topline and bottomline, but negative operating cashflow and Rs 9.39 cr fire loss are watch points.